Published in Brain Res on September 26, 2013
Restraint stress attenuates nicotine's locomotor stimulant but not discriminative stimulus effects in rats. Pharmacol Biochem Behav (2014) 0.77
Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus. PLoS One (2017) 0.75
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA (1999) 5.29
Sleep and depression. J Clin Psychiatry (2005) 2.78
Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol Psychiatry (2002) 2.49
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet (2002) 1.96
Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci (2000) 1.60
Methadone--metabolism, pharmacokinetics and interactions. Pharmacol Res (2004) 1.53
A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci (1996) 1.47
The anxiety disorder spectrum: fear imagery, physiological reactivity, and differential diagnosis. Anxiety Stress Coping (2009) 1.39
The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol Sci (1992) 1.38
Psychophysiology of post-traumatic stress disorder. Psychiatr Clin North Am (2002) 1.35
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
Neural systems underlying opiate addiction. J Neurosci (2002) 1.33
Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing. Neuropsychopharmacology (2003) 1.26
Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther (1995) 1.17
Circadian rhythms and depression: human psychopathology and animal models. Neuropharmacology (2011) 1.16
Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry (1994) 1.16
The chronometry of affective startle modulation in unipolar depression. J Abnorm Psychol (2008) 1.11
Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res (2006) 1.10
Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci (1998) 1.07
Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav (1998) 1.07
Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP). Psychopharmacology (Berl) (1997) 1.05
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments. Addict Biol (2003) 1.04
Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology (2007) 1.01
Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J Neurosci (2004) 1.00
Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis (1992) 0.97
Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) (2003) 0.97
Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats. J Pharmacol Exp Ther (1973) 0.96
Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacol Biochem Behav (2008) 0.95
Timing of fear expression in trace and delay conditioning measured by fear-potentiated startle in rats. Learn Mem (2004) 0.95
Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence. J Pharmacol Exp Ther (2003) 0.94
Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys. Psychopharmacology (Berl) (2008) 0.93
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology (2009) 0.92
Circadian modulation of the rat acoustic startle response. Behav Neurosci (1992) 0.92
Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal. J Nerv Ment Dis (1985) 0.89
Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase. Eur J Clin Pharmacol (1982) 0.87
Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology (2012) 0.87
Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology (2010) 0.87
Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates. Am J Psychiatry (1979) 0.86
Circadian alteration in neurobiology during protracted opiate withdrawal in rats. J Neurochem (2010) 0.85
Quantifiable dose-dependent withdrawal after morphine discontinuation in a rat model. Pharmacol Biochem Behav (2001) 0.85
Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav (1994) 0.85
Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients. Psychopharmacology (Berl) (1995) 0.84
Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys. Behav Pharmacol (2005) 0.84
Involvement of the dorsal periaqueductal gray in the loss of fear-potentiated startle accompanying high footshock training. Behav Neurosci (1997) 0.84
HPA axis dysregulation following prenatal opiate exposure and postnatal withdrawal. Neurotoxicol Teratol (2005) 0.83
Circadian modulation in the rat acoustic startle circuit. Behav Neurosci (1995) 0.83
Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats. Int J Neuropsychopharmacol (2013) 0.82
Direct input from cochlear root neurons to pontine reticulospinal neurons in albino rat. J Comp Neurol (2003) 0.82
Locomotor activity in morphine-dependent and post-dependent rats. Pharmacol Biochem Behav (1981) 0.82
Continuous quantitative monitoring of spontaneous opiate withdrawal: locomotor activity and sleep disorders. Pharmacol Biochem Behav (1998) 0.82
Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states. Psychopharmacology (Berl) (2001) 0.82
Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Psychopharmacology (Berl) (2004) 0.82
Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology (Berl) (1995) 0.81
Changes in locomotor-activity patterns as a measure of spontaneous morphine withdrawal: no effect of clonidine. Drug Alcohol Depend (1988) 0.80
Detoxification of rehabilitated methadone-maintained patients. JAMA (1973) 0.80
Cocaine-induced changes in affective state modulate the light-enhanced startle response. Behav Brain Res (2010) 0.80
Metabolism and disposition of l-alpha-acetylmethadol in the rat. Drug Metab Dispos (1977) 0.79
Disruption of diurnal feeding patterns of rats by heroin. Pharmacol Biochem Behav (1976) 0.79
Spontaneous withdrawal in opiate-dependent Fischer 344, Lewis and Sprague-Dawley rats. Pharmacol Biochem Behav (2010) 0.79
The acoustic startle response as a measure of behavioral dependence in rats. Psychopharmacology (Berl) (1992) 0.79
Effect of morphine withdrawal on food and water intake, urine output and electrolyte excretion in the rat: participation of the renin-aldosterone-system in renal excretory changes. Acta Physiol Hung (1984) 0.78
Anxiety-like symptoms induced by morphine withdrawal may be due to the sensitization of the dorsal periaqueductal grey. Physiol Behav (2008) 0.78
Prenatal levo-alpha-acetylmethadol (LAAM) and/or naloxone: effects on brain chemistry and postweaning behavior. Neurobehav Toxicol Teratol (1984) 0.77
Changes in plasma corticosterone levels as a measure of acute dependence upon levorphanol in rats. J Pharmacol Exp Ther (1979) 0.77
Spontaneous vs. naloxone-induced abstinence in dependent rats self-administering L-alpha-acetylmethadol (LAAM) or morphine. Pharmacol Biochem Behav (1979) 0.76
Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal. PLoS One (2013) 0.76
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med (2013) 3.27
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood (2011) 2.24
Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality. Blood (2013) 1.82
Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. J Pharmacol Exp Ther (2008) 1.16
Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) (2003) 0.97
Dissociable effects of hippocampus lesions on expression of fear and trace fear conditioning memories in rats. Hippocampus (2006) 0.97
Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats. Pharmacol Biochem Behav (2009) 0.97
The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior. Neuropsychopharmacology (2005) 0.96
Timing of fear expression in trace and delay conditioning measured by fear-potentiated startle in rats. Learn Mem (2004) 0.95
Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2011) 0.94
Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake. Psychopharmacology (Berl) (2012) 0.93
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal. Psychopharmacology (Berl) (2005) 0.93
Canonical TGF-beta signaling is required for the balance of excitatory/inhibitory transmission within the hippocampus and prepulse inhibition of acoustic startle. J Neurosci (2010) 0.92
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology (2009) 0.92
Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy. Int Immunopharmacol (2011) 0.91
Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex. Hippocampus (2013) 0.89
An anatomical basis for opponent process mechanisms of opiate withdrawal. J Neurosci (2011) 0.89
Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia. Psychopharmacology (Berl) (2007) 0.88
Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats. Psychopharmacology (Berl) (2009) 0.87
Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. Neuropsychopharmacology (2012) 0.87
Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology (2010) 0.87
Hippocampal activity, but not plasticity, is required for early consolidation of fear conditioning with a short trace interval. Eur J Neurosci (2007) 0.85
High throughput sequential ELISA for validation of biomarkers of acute graft-versus-host disease. J Vis Exp (2012) 0.85
Emotional reactivity to emotional and smoking cues during smoking abstinence: potentiated startle and P300 suppression. Psychophysiology (2011) 0.85
HPA axis dysregulation following prenatal opiate exposure and postnatal withdrawal. Neurotoxicol Teratol (2005) 0.83
Multigenerational effects of fetal-neonatal iron deficiency on hippocampal BDNF signaling. Physiol Rep (2013) 0.83
Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Psychopharmacology (Berl) (2004) 0.82
Effects of chronic hypoxia in developing rats on dendritic morphology of the CA1 subarea of the hippocampus and on fear-potentiated startle. Brain Res (2007) 0.79
Protracted manifestations of acute dependence after a single morphine exposure. Psychopharmacology (Berl) (2011) 0.79
Role of corticosterone in trace and delay conditioned fear-potentiated startle in rats. Behav Neurosci (2010) 0.78
Effects of age, but not sex, on elevated startle during withdrawal from acute morphine in adolescent and adult rats. Behav Pharmacol (2015) 0.76
Correction: The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats. PLoS One (2015) 0.75
Recurrent Moderate Hypoglycemia Suppresses Brain-Derived Neurotrophic Factor Expression in the Prefrontal Cortex and Impairs Sensorimotor Gating in the Posthypoglycemic Period in Young Rats. Dev Neurosci (2016) 0.75